Journal of Korean Traditional Oncology (대한암한의학회지)

Korean Association of Traditional Oncology (대한암한의학회)
권호 표지
DOI QR코드

DOI QR Code

Preliminary Study for Development of Korean Medicine Clinical Practice Guideline for Pancreatic Cancer

췌장암 한의 임상진료지침 개발 예비 연구

  • Park, Soo-Jung (Department of Sasang Constitutional Medicine, College of Korean Medicine, Woosuk University) ;
  • Yoo, Hwa-Seung (East-West Cancer Center, Dunsan Korean Medicine Hospital of Daejeon University) ;
  • Yu, Jun-Sang (Department of Sasang Constitutional Medicine, College of Korean Medicine, Sangji University)
  • 박수정 (우석대학교 한의과대학 사상체질과) ;
  • 유화승 (대전대학교 둔산한방병원 동서암센터) ;
  • 유준상 (상지대학교 한의과대학 사상체질과)
  • Received : 2017.05.02
  • Accepted : 2017.06.10
  • Published : 2017.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objectives: The purpose of this study is to investigate preliminarily for development of the Korean medicine clinical practice guideline (CPG) for pancreatic cancer through the analysis of existing CPGs. Methods: Through searching the medical database such as Pubmed, SCOPUS, CNKI, Google Scholar, etc. The global CPGs within recent three years were collected and analyzed. In particular, recommendations related to the Korean medicine or Chinese medicine were made primarily in the Guidelines of Diagnosis and Therapy in Oncology with Traditional Chinese Medicine. Results: The six CPGs were mentioned in this study. The academic societies and organizations developing the CPGs were located in China, Japan, Europe and America. The contents of the CPGs were the clinical questions and statements, surgical therapy, adjuvant therapy, radiation therapy, chemotherapy, palliative medicine, risk assessment, palliation and supportive care, follow-up and recurrence, Tumor-Node-Metastasis (TNM) staging. In the Guidelines of Diagnosis and Therapy in Oncology with Traditional Chinese Medicine, the etiology, mechanisms, herbal drugs, Chinese medicine assessment, complication, syndrome differentiation (SD), Chinese medicine treatment were described. Conclusions: In order to develop the proper Korean medicine CPG for pancreatic cancer and to adapt the correct integrative treatment program on the pancreatic cancer, institutional arrangements for cooperation with Korean medical communities and standardization of SD should be performed.

Keywords

References

  1. 국가암정보센터. 통계로 보는 암. 2017. Available from: http://www.cancer.go.kr
  2. 임상진료지침 정보센터. 국내 임상진료지침. 2017. Available from: http://www.guideline.or.kr
  3. 류지곤. 절제 불가능한 췌장암 항암치료의 최신 지견. Korean J Gastroenterol 66(3):150-153, 2015 https://doi.org/10.4166/kjg.2015.66.3.150
  4. 방승민. 췌장암의 감시와 조기 진단. The Korean Journal of Pancreas and Biliary Tract 20(1):1-4, 2015 https://doi.org/10.15279/kpba.2015.20.1.1
  5. 이우진, 우상명. What is the best management for borderline resectable pancreatic cancer?. 대한췌담도학회지 17(1s):73-81, 2012
  6. 김효린, 정혜련, 백동기, 원진희, 문구. 위암 치료에 대한 한방 임상 가이드라인. 대한암한의학회지 19(1):1-24, 2014 https://doi.org/10.15432/JKTO.2014.19.1.1
  7. 홍상훈, 손호영. 간세포암종 치료에 대한 한의 임상 가이드라인. 대한암한의학회지 20(1):55-79, 2015 https://doi.org/10.15432/JKTO.2015.20.1.055
  8. 김경순, 최홍식, 김승모, 유화승. 난소암 치료에 대한 한의 임상 가이드라인. 대한암한의학회지 21(2):37-50, 2016 https://doi.org/10.15432/JKTO.2016.21.2.037
  9. 김준영, 유화승, 조정효. 결장직장암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구. 한의학연구소 논문집 24(2):65-83, 2016
  10. 박태열, 유화승, 이상헌. 방광암의 한의학적 진료지침 개발을 위한 기초 연구. 대한한방내과학회지 37(6):911-928, 2016 https://doi.org/10.22246/jikm.2016.37.6.911
  11. 이남헌, 이강욱, 유화승, 이진선. 유방암 치료에 대한 한의 임상 가이드라인 개발을 위한 기초연구. 대한한방부인과학회지 29(2):47-65, 2016 https://doi.org/10.15204/JKOBGY.2016.29.2.047
  12. 이종훈, 강세영, 유화승. 비인두암의 한의학적 진료 지침 개발을 위한 기초 연구. 대한한방내과학회지 37(3):516-528, 2016
  13. 정현식, 이상헌, 유화승, 김경석. 악성 림프종 치료에 대한 한의 임상진료지침. 대한한방내과학회지 37(3):453-466, 2016
  14. 정현정, 유화승. 자궁경부암의 한의학적 진료에 대한 고찰. 대한암한의학회지 21(1):1-14, 2016 https://doi.org/10.15432/JKTO.2016.21.1.001
  15. 송봉근, 이언정, 유화승. 전립선암 치료의 한방 임상 진료 지침. 대한암한의학회지 21(2):1-36, 2017 https://doi.org/10.15432/JKTO.2016.21.2.001
  16. 주현아, 배현진, 황충연. 인진과 황련 추출물의 췌장암 세포주 MIA PaCa-2에 대한 세포사멸 효과. 한방안이비인후피부과학회지 27(4):158-176, 2014 https://doi.org/10.6114/JKOOD.2014.27.4.158
  17. 김훈, 원진희, 문구. 부정항암탕의 사람 췌장암 세포주 Panc-1에 대한 항종양 효과. 대한한의학방제학회지 15(1):213-228, 2007
  18. 이인영, 정황산, 원진희. 췌장암 세포주 MIA PaCa-2에서 황백 물 추출물에 의한 Apoptosis 유도 및 작용기전. 동의생리병리학회지 27(2):202-211, 2013
  19. 방선휘, 이종훈, 조정효, 이연월, 손창규, 조종관, 유화승, 림프절 전이를 동반한 췌장암환자 1례에 대한 보고. 대한한방내과학회지 28(4):948-955, 2007
  20. 김종민, 박재우, 유화승, 이연월, 조종관. 췌장암의 외과적 절제술 후 항암플러스로 항전이 및 재발 방지 중인 환자 증례 보고. 대한암한의학회지 16(1):33-39, 2011
  21. 박상은, 서상호, 홍수현, 김재연, 신원탁, 윤현민, 홍상훈. 약침요법을 통한 췌장암 환자의 천증 치험 1례. 대한약침학회지 9(1):59-67, 2006 https://doi.org/10.3831/KPI.2006.9.1.059
  22. 윤호영, 조종관, 유화승, 방선휘. 한방치료를 통해 수술이 불가능한 췌장암 환자에서 통증개선 및 삶의 질을 회복한 증례. 대한암한의학회지 18(1):9-15, 2013
  23. 임홍생. 악성종류중의진료지남. p.400-421, 중국, 인민위생출판사, 2014
  24. Yamaguchi K, Okusaka T, Shimizu K, Furuse J, Ito Y, Hanada K, et al. Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis. Pancreas 46(5):595-604, 2017 https://doi.org/10.1097/MPA.0000000000000816
  25. Ducreux M, Cuhna AS, Caramella C, Hollebecque A, Burtin P, Goere D, et al. Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of oncology : official journal of the European Society for Medical Oncology 26 Suppl 5:v56-68, 2015 https://doi.org/10.1093/annonc/mdv295
  26. Szmola R, Farkas G, Hegyi P, Czako L, Dubravcsik Z, Hritz I, et al. Pancreatic cancer. Evidence based management guidelines of the Hungarian Pancreatic Study Group. Orvosi hetilap 156(8):326-339, 2015 https://doi.org/10.1556/OH.2015.30063
  27. Balaban EP, Mangu PB, Yee NS. Locally Advanced Unresectable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline Summary. Journal of oncology practice 13(4):265-269, 2017 https://doi.org/10.1200/JOP.2016.017376
  28. Sohal DP, Mangu PB, Khorana AA, Shah MA, Philip PA, O'Reilly EM, et al. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(23):2784-2796, 2016 https://doi.org/10.1200/JCO.2016.67.1412
  29. Khorana AA, Mangu PB, Berlin J, Engebretson A, Hong TS, Maitra A, et al. Potentially Curable Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 34(21):2541-2556, 2016 https://doi.org/10.1200/JCO.2016.67.5553
  30. Network NCC. NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) - Pancreatic Adenocarcinoma 2015. Available from: http://www.tri-kobe.org/nccn/guideline/pancreas/english/pancreatic.pdf
  31. Nie J, Zhao C, Deng LI, Chen J, Yu B, Wu X, Pang P, Chen X. Efficacy of traditional Chinese medicine in treating cancer. Biomedical reports 4(1):3-14, 2016 https://doi.org/10.3892/br.2015.537
  32. Ma Y, Wu Q, Li X, Gu X, Xu J, Yang J. Pancreatic cancer: from bench to bedside. Ann Transl Med 4(23):458, 2017
  33. Li B, Gan R, Yang Q, Huang J, Chen P, Wan L, Guo C. Chinese Herbal Medicines as an Adjunctive Therapy for Unresectable Pancreatic Cancer: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med 2015:350730, 2015
  34. Yang X, Hao J, Zhu CH, Niu YY, Ding XL, Liu C, Wu XZ. Survival Benefits of Western and Traditional Chinese Medicine Treatment for Patients With Pancreatic Cancer. Medicine (Baltimore) 94(26):e1008, 2015 https://doi.org/10.1097/MD.0000000000001008
  35. Saif MW. Is there a role for herbal medicine in the treatment of pancreatic cancer? Jop 9(4):403-407, 2008
  36. Cohen L, Markman M. 대전대학교 둔산한방병원 동서암센터 역. 통합암치료. 서울, 이퍼블릭, 2010
  37. 대한암한의학회 교재편찬위원회. 한의통합종양학. 서울, 군자출판사, 2013
  38. Ezzo JM, Richardson MA, Vickers A, Allen C, Dibble SL, Issell BF, Lao L, Pearl M, Ramirez G, Roscoe J, Shen J, Shivnan JC, Streitberger K, Treish I, Zhang G. Acupuncture-point stimulation for chemotherapy-induced nausea or vomiting. Cochrane Database Syst Rev 19;(2):CD002285, 2006
  39. Lee A, Done ML. The use of nonpharmacologic techniques to prevent postoperative nausea and vomiting: a meta-analysis. Anesth Analg 88(6):1362-1369, 1999 https://doi.org/10.1213/00000539-199906000-00031
  40. Linde K, Mulrow CD, Berner M, Egger M. St John's wort for depression. Cochrane Database Syst Rev 18;(2):CD000448, 2005
  41. Astin JA, Shapiro SL, Eisenberg DM, Forys KL. Mind-body medicine: state of the science, implications for practice. J Am Board Fam Pract 16(2):131-147, 2003 https://doi.org/10.3122/jabfm.16.2.131
  42. Ji Q, Luo YQ, Wang WH, Liu X, Li Q, Su SB. Research advances in traditional Chinese medicine syndromes in cancer patients. J Integr Med 14(1):12-21, 2016 https://doi.org/10.1016/S2095-4964(16)60237-6
  43. Chen Z, Wang P. Clinical Distribution and Molecular Basis of Traditional Chinese Medicine ZHENG in Cancer. Evid Based Complement Alternat Med 783923, 2012
  44. Mei MF. A systematic analysis of the theory and practice of syndrome differentiation. Chin J Integr Med 17(11):803-810, 2011 https://doi.org/10.1007/s11655-011-0890-0